CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | COZADD BRUCE C Director | Sale | −27,714 | $234.91 | $6.5M | 398,661 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −10,688 | $235.82 | $2.5M | 387,973 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −24,483 | $236.84 | $5.8M | 363,490 |
| 2026-11-06 | COZADD BRUCE C Director | Sale | −5,923 | $237.39 | $1.4M | 357,567 |
| 2026-11-04 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,250 | $231.37 | $289K | 6,675 |
| 2026-11-04 | Carr Patricia SVP, Chief Accounting Officer | Sale | −163 | $231.27 | $38K | 6,512 |
| 2026-11-03 | GALA RENEE D President & CEO | Sale 10b5-1 | −1,000 | $225.37 | $225K | 140,394 |
| 2026-11-02 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $215.84 | $1.3M | 339,875 |
| 2026-10-06 | GALA RENEE D President & CEO | Sale 10b5-1 | −2,000 | $236.40 | $473K | 141,394 |
| 2026-10-01 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $230.33 | $1.4M | 345,875 |
| 2026-09-10 | Patil Neena M EVP & Chief Legal Officer | Sale 10b5-1 | −1,200 | $240.94 | $289K | 47,671 |
| 2026-09-08 | GALA RENEE D President & CEO | Sale 10b5-1 | −2,000 | $243.03 | $486K | 143,394 |
| 2026-09-01 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $250.13 | $1.5M | 351,875 |
| 2026-08-27 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −18,187 | $247.86 | $4.5M | 124,420 |
| 2026-08-27 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −11,423 | $248.67 | $2.8M | 112,997 |
| 2026-08-27 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −18,113 | $250.02 | $4.5M | 94,884 |
| 2026-08-27 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −19,639 | $250.60 | $4.9M | 75,245 |
| 2026-08-27 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −9,259 | $251.95 | $2.3M | 65,986 |
| 2026-08-27 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −300 | $252.76 | $76K | 65,686 |
| 2026-08-03 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $252.98 | $1.5M | 360,682 |
Page 1 of 13 · 246 trades